MedTrace Logo

Biological Effects of Treatment With Resveratrol in ART Patients

NCT04386499 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-05-13

No results posted yet for this study

Summary

To evaluate the effects of a new nutraceutical formulation containing resveratrol (trademark GENANTE) on gamete quality in order to improve the reproductive process during ART.

Conditions

  • Infertility, Female

Interventions

DIETARY_SUPPLEMENT

Resveratrol

mixture of trans-resveratrol 150 mg (REVIFAST), folic acid 400 mcg, vitamin D, vitamin B12 and vitamin B6

DIETARY_SUPPLEMENT

Folic acid

400 mcg of folic acid

Sponsors & Collaborators

  • University Of Perugia

    lead OTHER

Principal Investigators

  • Sandro Gerli, MD · University Of Perugia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-10
Primary Completion
2020-03-11
Completion
2020-05-05

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04386499 on ClinicalTrials.gov